Percutaneous coronary intervention of bifurcation coronary disease

Minerva Cardioangiologica

Volumn 55, Issue 1, 2007, Pages 57-70

  Suzuki, N ^a   Angiolillo, D J ^a   Kawaguchi, R ^a   Futamatsu, H ^a   Bass, T A ^a   Costa, M A ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Angioplasty, transluminal, percutaneous coronary; Coronary artery disease; Stents; Thrombosis

Indexed keywords

PACLITAXEL; RAPAMYCIN;

ANATOMICAL VARIATION; ANGIOCARDIOGRAPHY; ANGIOPLASTY; BIFURCATION CORONARY ARTERY DISEASE; BYPASS SURGERY; CLINICAL RESEARCH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CORONARY ARTERY DISEASE; DISEASE CLASSIFICATION; DRUG ELUTING STENT; HUMAN; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; REVIEW; TECHNIQUE; THROMBOSIS; ULTRASOUND;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERIOSCLEROSIS; CORONARY RESTENOSIS; HUMANS; RISK FACTORS; STENTS; TREATMENT OUTCOME;

EID: 33947574926     PISSN: 00264725     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (83)

1. Meier B, Gruentzig AR, King SB 3rd, Douglas JS Jr. Hollman J, Ischinger T et al. Risk of side branch occlusion during coronary angioplasty. Am J Cardiol 1984;53:10-4.
2. Renkin J, Wijns W, Hanet C, Michel X, Cosyns J, Col J. Angioplasty of coronary bifurcation stenoses: immediate and long-term results of the protecting branch technique. Cathet Cardiovasc Diagn 1991;22:167-73.
3. George BS, Myler RK, Stertzer SH, Clark DA, Cote G, Shaw RE et al. Balloon angioplasty of coronary bifurcation lesions: the kissing balloon technique. Cathet Cardiovasc Diagn 1986;12:124-38.
4. Ciampricotti R, el Gamal M, van Gelder B, Bonnier J, Taverne R. Coronary angioplasty of bifurcational lesions without protection of large side branches. Cathet Cardiovasc Diagn 1992;27:191-6.
5. Myler RK, Shaw RE, Stertzer SH, Hecht HS, Ryan C, Rosenblum J et al. Lesion morphology and coronary angioplasty: current experience and analysis. J Am Coll Cardiol 1992;19:1641-52.
6. Griffiths H, Bakhai A, West D, Petrou M, De Souza T, Moat N et al. Feasibility and cost of treatment with drug eluting stents of surgical candidates with multi-vessel coronary disease. Eur J Cardiothorac Surg 2004;26:528-34.
7. Lemos PA, Serruys PW, van Domburg RT, Saia F, Arampatzis CA, Hoye A et al. Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the "real world": the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry. Circulation 2004;109:190-5.
8. Ong AT, Hoye A, Aoki J, van Mieghem CA, Rodriguez Granillo GA, Sonnenschein K et al. Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation. J Am Coll Cardiol 2005;45:947-53.
9. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005;293:2126-30.
10. Kuchulakanti PK, Chu WW, Torguson R, Ohlmann P, Rha SW, Clavijo LC et al. Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents. Circulation 2006;113:1108-13.
11. Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 2006;48:193-202.
12. Arampatzis CA, Lemos PA, Tanabe K, Hoye A, Degertekin M, Saia F et al. Effectiveness of sirolimus-eluting stent for treatment of left main coronary artery disease. Am J Cardiol 2003;92:327-9.
13. de Lezo JS, Medina A, Pan M, Delgado A, Segura J, Pavlovic D et al. Rapamycin-eluting stents for the treatment of unprotected left main coronary disease. Am Heart J 2004;148:481-5.
14. Chieffo A, Morici N, Maisano F, Bonizzoni E, Cosgrave J, Montorfano M et al. Percutaneous treatment with drug-eluting stent implantation versus bypass surgery for unprotected left main stenosis: a single-center experience. Circulation 2006;113:2542-7.
15. WRITING COMMITTEE MEMBERS. ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention. Available at: http://www.americanheart. org/downloadable/heart/1131740149971PCI_Final%20Fi nal%20Clean%20Revision_AHA. pdf Accessed December 24 2006.
16. Silber S, Albertsson P, Aviles FF, Camici PG, Colombo A, Hamm C et al. Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J 2005;26:804-47.
17. Price MJ, Cristea E, Sawhney N, Kao JA, Moses JW, Leon MB et al. Serial angiographic follow-up of sirolimus-eluting stents for unprotected left main coronary artery revascularization. J Am Coll Cardiol 2006;47:871-7.
18. Valgimigli M, Malagutti P, Rodriguez-Granillo GA, Garcia-Garcia HM, Polad J, Tsuchida K et al. Distal left main coronary disease is a major predictor of outcome in patients undergoing percutaneous intervention in the drug-eluting stent era: an integrated clinical and angiographic analysis based on the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) and Taxus-Stent Evaluated At Rotterdam Cardiology Hospital (T-SEARCH) registries. J Am Coll Cardiol 2006;47:1530-7.
19. Briguori C, Airoldi F, Chieffo A, Montorfano M, Carlino M, Sangiorgi GM et al. Elective versus provisional intraaortic balloon pumping in unprotected left main stenting. Am Heart J 2006;152:565-72.
20. Hoye A, Iakovou I, Ge L, van Mieghem CA, Ong AT, Cosgrave J et al. Long-term outcomes after stenting of bifurcation lesions with the "crush" technique: predictors of an adverse outcome. J Am Coll Cardiol 2006;47:1949-58.
21. Valgimigli M, Malagutti P, Rodriguez Granillo GA, Tsuchida K, Garcia-Garcia HM, van Mieghem CA et al. Single-vessel versus bifurcation stenting for the treatment of distal left main coronary artery disease in the drug-eluting stenting era. Clinical and angiographic insights into the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) and Taxus-Stent Evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registries. Am Heart J 2006;152:896-902.
22. Tan WA, Tamai H, Park SJ, Plokker HW, Nobuyoshi M, Suzuki T et al. Long-term clinical outcomes after unprotected left main trunk percutaneous revascularization in 279 patients. Circulation 2001;104:1609-14.
23. Popma JJ, Leon MB, Topol EJ. Atlas of Interventional Cardiology. Philadelphia, PA: Saunders; 1994.
24. Spokojny AM, Sanborn TM. The bifurcation lesion. In: Ellis SG, Holmes DRJ, editors. Strategic approaches in coronary intervention. Baltimore, MD: Williams and Wilkins; 1996.p.288.
25. Safian RD. Bifurcation lesions. In: Safian RD, Freed MS, editors. the manual of interventional cardiology. Royal Oak, MI: Physician's Press; 2001.p.222.
26. Lefevre T, Louvard Y, Morice MC, Dumas P, Loubeyre C, Benslimane A et al. Stenting of bifurcation lesions: classification, treatments, and results. Catheter Cardiovasc Interv 2000;49:274-83.
27. Movahed MR, Stinis CT. A new proposed simplified classification of coronary artery bifurcation lesions and bifurcation interventional techniques. J Invasive Cardiol 2006;18:199-204.
28. Medina A, Suarez de Lezo J, Pan M. [A new classification of coronary bifurcation lesions]. Rev Esp Cardiol 2006;59:183.
29. Ormiston JA, Currie E, Webster MW, Kay P, Ruygrok PN, Stewart JT et al. Drug-eluting stents for coronary bifurcations: insights into the crush technique. Catheter Cardiovasc Interv 2004;63:332-6.
30. Dzavik V, Kharbanda R, Ivanov J, Ing DJ, Bui S, Mackie K et al. Predictors of long-term outcome after crush stenting of coronary bifurcation lesions: importance of the bifurcation angle. Am Heart J 2006;152:762-9.
31. Boxt LM, Meyerovitz MF, Taus RH, Ganz P, Friedman PL, Levin DC. Side branch occlusion complicating percutaneous transluminal coronary angioplasty. Radiology 1986;161:681-3.
32. Weinstein JS, Baim DS, Sipperly ME, McCabe CH, Lorell BH. Salvage of branch vessels during bifurcation lesion angioplasty: acute and long-term follow-up. Cathet Cardiovasc Diagn 1991;22:1-6.
33. Vetrovec GW, Cowley MJ, Wolfgang TC, Ducey KC. Effects of percutaneous transluminal coronary angioplasty on lesion-associated branches. Am Heart J 1985;109(5 Pt 1):921-5.
34. Arora RR, Raymond RE, Dimas AP, Bhadwar K, Simpfendorfer C. Side branch occlusion during coronary angioplasty: incidence, angiographic characteristics, and outcome. Cathet Cardiovasc Diagn 1989;18:210-2.
35. Ahmed JM, Mintz GS, Weissman NJ, Lansky AJ, Pichard AD, Satler LF et al. Mechanism of lumen enlargement during intracoronary stent implantation: an intravascular ultrasound study. Circulation 2000;102:7-10.
36. Koo BK, Kang HJ, Youn TJ, Chae IH, Choi DJ, Kim HS et al. Physiologic assessment of jailed side branch lesions using fractional flow reserve. J Am Coll Cardiol 2005;46:633-7.
37. Costa RA, Moussa ID. Percutaneous treatment of coronary bifurcation lesions in the era of drug-eluting stents. Minerva Cardioangiol 2006;54:577-89.
38. Costa RA, Mintz GS, Carlier SG, Lansky AJ, Moussa I, Fujii K et al. Bifurcation coronary lesions treated with the "crush" technique: an intravascular ultrasound analysis. J Am Coll Cardiol 2005;46:599-605.
39. Pao YC, Lu JT, Ritman EL. Bending and twisting of an in vivo coronary artery at a bifurcation. J Biomech 1992;25:287-95.
40. Gradaus R, Mathies K, Breithardt G, Bocker D. Clinical assessment of a new real time 3D quantitative coronary angiography system: evaluation in stented vessel segments. Cathet Cardiovasc Interv 2006;68:44-9.
41. Ge L, Airoldi F, Iakovou I, Cosgrave J, Michev I, Sangiorgi GM et al. Clinical and angiographic outcome after implantation of drug-eluting stents in bifurcation lesions with the crush stent technique: importance of final kissing balloon post-dilation. J Am Coll Cardiol 2005;46:613-20.
42. Lefevre T, Ormiston J, Guagliumi G, Schultheiss HP, Quilliet L, Reimers B et al. The Frontier stent registry: safety and feasibility of a novel dedicated stent for the treatment of bifurcation coronary artery lesions. J Am Coll Cardiol 2005;46:592-8.
43. Steigen TK, Maeng M, Wiseth R, Erglis A, Kumsars I, Narbute I et al. Randomized study on simple versus complex stenting of coronary artery bifurcation lesions: the Nordic bifurcation study. Circulation 2006;114:1955-61.
44. Rieber J, Huber A, Erhard I, Mueller S, Schweyer M, Koenig A et al. Cardiac magnetic resonance perfusion imaging for the functional assessment of coronary artery disease: a comparison with coronary angiography and fractional flow reserve. Eur Heart J 2006;27:1465-71.
45. Costa MA, Sabate M, Staico R, Alfonso F, Seixas AC, Albertal M et al. Anatomical and physiologic assessments in patients with small coronary artery disease: final results of the PHANTOM trial. Am Heart J. In press 2007.
46. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002;346:1773-80.
47. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003;349:1315-23.
48. Sabate M, Jimenez-Quevedo P, Angiolillo DJ, Gomez-Hospital JA, Alfonso F, Hernandez-Antolin R et al. Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: the diabetes and sirolimus-eluting stent (DIABETES) trial. Circulation 2005;112:2175-83.
49. Morice MC, Colombo A, Meier B, Serruys P, Tamburino C, Guagliumi G et al. Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial. JAMA 2006;295:895-904.
50. Pan M, Suarez de Lezo J, Medina A, Romero M, Delgado A, Segura J et al. Drug-eluting stents for the treatment of bifurcation lesions: a randomized comparison between paclitaxel and sirolimus stents. Am Heart J 2007;153:e1-7.
51. Kastrati A, Dibra A, Eberle S, Mehilli J, Suarez de Lezo J, Goy JJ et al. Sirolimus-eluting stents vs paclitaxel-eluting stents in patients with coronary artery disease: meta-analysis of randomized trials. JAMA 2005;294:819-25.
52. Windecker S, Remondino A, Eberli FR, Juni P, Raber L, Wenaweser P et al. Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization. N Engl J Med 2005;353:653-62.
53. Al Suwaidi J, Yeh W, Cohen HA, Detre KM, Williams DO, Holmes DR Jr. Immediate and one-year outcome in patients with coronary bifurcation lesions in the modern era (NHLBI dynamic registry). Am J Cardiol 2001;87:1139-44.
54. Yamashita T, Nishida T, Adamian MG, Briguori C, Vaghetti M, Corvaja N et al. Bifurcation lesions: two stents versus one stent - immediate and follow-up results. J Am Coll Cardiol 2000;35:1145-51.
55. Cervinka P, Stasek J, Pleskot M, Maly J. Treatment of coronary bifurcation lesions by stent implantation only in parent vessel and angioplasty in sidebranch: immediate and long-term outcome. J Invasive Cardiol 2002;14:735-40.
56. Assali AR, Teplitsky I, Hasdai D, Rechavia E, Solodky A, Sela O et al. Coronary bifurcation lesions: to stent one branch or both? J Invasive Cardiol 2004;16:447-50.
57. Costa MA, Tannenbaum M, Angiolillo DJ, Fenster M, Chu AA, Driesman M et al. Insidence and clinical impact of deployment techniques and geographical miss during implantation of sirolimus-eluting stents: Insights from the STLLR. trial. Circulation 2005;112:U802.
58. Colombo A, Stankovic G, Orlic D, Corvaja N, Liistro F, Airoldi F et al. Modified T-stenting technique with crushing for bifurcation lesions: immediate results and 30-day outcome. Catheter Cardiovasc Interv 2003;60:145-51.
59. Colombo A, Moses JW, Morice MC, Ludwig J, Holmes DR Jr, Spanos V et al. Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions. Circulation 2004;109:1244-9.
60. Pan M, de Lezo JS, Medina A, Romero M, Segura J, Pavlovic D et al. Rapamycin-eluting stents for the treatment of bifurcated coronary lesions: a randomized comparison of a simple versus complex strategy. Am Heart J 2004;148:857-64.
61. Assali AR, Assa HV, Ben-Dor I, Teplitsky I, Solodky A, Brosh D et al. Drug-eluting stents in bifurcation lesions: to stent one branch or both? Catheter Cardiovasc Interv 2006;68:891-6.
62. Iakovou I, Ge L, Colombo A. Contemporary stent treatment of coronary bifurcations. J Am Coll Cardiol 2005;46:1446-55.
63. Schampaert E, Fort S, Adelman AG, Schwartz L. The V-stent: a novel technique for coronary bifurcation stenting. Cathet Cardiovasc Diagn 1996;39:320-6.
64. Colombo A, Gaglione A, Nakamura S, Find L. "Kissing" stents for bifurcational coronary lesion. Cathet Cardiovasc Diagn 1993;30:327-30.
65. Carrie D, Elbaz M, Dambrin G, Saint-Cricq F, Dugrand P, Fourcade J et al. Coronary stenting of bifurcation lesions using "T" or "reverse Y" configuration with Wiktor stent. Am J Cardiol 1998;82:1418-21, A8.
66. Carrie D, Karouny E, Chouairi S, Puel J. "T"-shaped stent placement: a technique for the treatment of dissected bifurcation lesions. Cathet Cardiovasc Diagn 1996;37:311-3.
67. Kobayashi Y, Colombo A, Akiyama T, Reimers B, Martini G, di Mario C. Modified "T" stenting: a technique for kissing stents in bifurcational coronary lesion. Cathet Cardiovasc Diagn 1998;43:323-6.
68. Chevalier B, Glatt B, Royer T, Guyon P. Placement of coronary stents in bifurcation lesions by the "culotte" technique. Am J Cardiol 1998;82:943-9.
69. Sharma SK, Choudhury A, Lee J, Kim MC, Fisher E, Steinheimer AM et al. Simultaneous kissing stents (SKS) technique for treating bifurcation lesions in medium-to-large size coronary arteries. Am J Cardiol 2004;94:913-7.
70. Fort S, Lazzam C, Schwartz L. Coronary 'Y' stenting: a technique for angioplasty of bifurcation stenoses. Can J Cardiol 1996;12:678-82.
71. Alberti A, Missiroli B, Nannini C. "Skirt" technique for coronary artery bifurcation stenting. J Invasive Cardiol 2000;12:633-6.
72. Ge L, Iakovou I, Cosgrave J, Agostoni P, Airoldi F, Sangiorgi GM et al. Treatment of bifurcation lesions with two stents: one year angiographic and clinical follow up of crush versus T stenting. Heart 2006;92:371-6.
73. Moussa I, Costa RA, Leon MB, Lansky AJ, Lasic Z, Cristea E et al. A prospective registry to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions using the "crush technique". Am J Cardiol 2006;97:1317-21.
74. Tanabe K, Hoye A, Lemos PA, Aoki J, Arampatzis CA, Saia F et al. Restenosis rates following bifurcation stenting with sirolimus-eluting stents for de novo narrowings. Am J Cardiol 2004;94:115-8.
75. Ge L, Tsagalou E, Iakovou I, Sangiorgi GM, Corvaja N, Airoldi F et al. In-hospital and nine-month outcome of treatment of coronary bifurcational lesions with sirolimus-eluting stent. Am J Cardiol 2005;95:757-60.
76. Cervinka P, Foley DP, Sabate M, Costa MA, Serrano P, Ligthart JM et al. Coronary bifurcation stenting using dedicated bifurcation stents. Catheter Cardiovasc Interv 2000;49:105-11.
77. Aziz S, Morris JL. Transradial treatment of bifurcation coronary disease using the Multi-Link Frontier bifurcation stent system. J Invasive Cardiol 2005;17:E1-3.
78. Toutouzas K, Stankovic G, Takagi T, Albiero R, Corvaja N, Milici C et al. A new dedicated stent and delivery system for the treatment of bifurcation lesions: preliminary experience. Catheter Cardiovasc Interv 2003;58:34-42.
79. Ikeno F, Kim YH, Luna J, Condado JA, Colombo A, Grube E et al. Acute and long-term outcomes of the novel side access (SLK-View) stent for bifurcation coronary lesions: a multicenter nonrandomized feasibility study. Catheter Cardiovasc Interv 2006;67:198-206.
80. Miyazawa A, Webster MW, Fitzgerald PJ, Ormiston JA. Novel stent system for bifurcation lesions: examination by intravascular ultrasound. Catheter Cardiovasc Interv 2006;67:900-3.
81. Ikeno F, Kaneda H, Ormiston JA, Rezaee M, Fitzgerald PJ, Yeung AC et al. AST-PETAL: Novel stent and delivery system for the treatment of bifurcation lesions. Am J Cardiol 2004;94(Suppl 6A):182E.
82. Cilingiroglu M, Elliott J, Patel D, Tio F, Matthews H, McCasland M et al. Long-term effects of novel biolimus eluting DEVAX AXXESS plus nitinol self-expanding stent in a porcine coronary model. Catheter Cardiovasc Interv 2006;68:271-9.
83. Miyazawa A, Ako J, Hassan AH, Abizaid A, Verheye S, McClean D et al. Intravascular ultrasound analysis of bifurcation lesions treated with a novel drug-eluting dedicated bifurcation stent system: intravascular ultrasound results of the AXXESS plus trial. Am J Cardiol 2006;98:41M.